#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	3898	16S	1529	1529	99.93	16S.l6.c17.ctg.1	2472	463.3	0	.	n	.	0	C451T	SNP	451	451	C	776	776	T	572	T,C	353,130	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	3898	16S	1529	1529	99.93	16S.l6.c17.ctg.1	2472	463.3	1	SNP	n	C1184T	0	.	.	1184	1184	C	1509	1509	C	541	C,A	455,1	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	3898	16S	1529	1529	99.93	16S.l6.c17.ctg.1	2472	463.3	0	HET	.	.	.	C207T,A,G	.	207	207	C	532	532	C	545	C,T,A,G	338,109,2,1	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	3898	16S	1529	1529	99.93	16S.l6.c17.ctg.1	2472	463.3	0	HET	.	.	.	C1450T,G	.	1450	1450	C	1775	1775	C	583	C,T,G	390,125,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	6328	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3924	482.3	0	.	n	.	0	T695C	SNP	695	695	T	1200	1200	C	484	C	408	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	6328	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3924	482.3	0	.	n	.	0	T1971C	SNP	1971	1971	T	2476	2476	C	650	C,A,T	531,2,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	6328	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3924	482.3	1	SNP	n	C2597T	1	C2597T	SNP	2597	2597	C	3102	3102	T	524	T	432	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	6328	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3924	482.3	1	SNP	n	A2045G	0	.	.	2045	2045	A	2550	2550	A	660	A,C	558,1	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
folP.WHO_V_01427c	folP.WHO_V_01427c	1	1	27	624	folP	855	855	100.0	folP.l15.c4.ctg.1	1967	94.9	1	SNP	p	R229S	1	.	.	685	687	AGC	1208	1210	AGC	142;142;141	A,C;G;C	121,1;124;122	folP.WHO_V_01427c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	1358	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3911	104.1	1	SNP	p	S91F	1	.	.	271	273	TTC	759	761	TTC	116;116;115	T;T;C,A	101;99;101,1	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	1358	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3911	104.1	1	SNP	p	D95G	1	.	.	283	285	GGC	771	773	GGC	112;111;111	G;G;C	98;93;96	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	1358	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3911	104.1	1	SNP	p	G95N	0	.	.	283	285	GGC	771	773	GGC	112;111;111	G;G;C	98;93;96	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_X_01389	mtrR.WHO_X_01389	1	1	27	652	mtrR	633	633	100.0	mtrR.l15.c4.ctg.1	1605	121.1	1	SNP	p	G45D	0	.	.	133	135	GGC	619	621	GGC	177;176;176	G;G;C	154;150;155	mtrR.WHO_X_01389:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	354	mtrR_promoter	250	250	99.6	mtrR_promoter.l6.c17.ctg.1	1322	80.3	0	.	n	.	0	A197.	DEL	197	197	A	725	725	A	167	A	134	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	1578	parC	2304	2304	100.0	parC.l6.c4.ctg.1	3429	137.9	1	SNP	p	D86N	0	.	.	256	258	GAC	744	746	GAC	172;172;172	G;A;C	140;135;145	parC.WHO_Y_00247c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	1578	parC	2304	2304	100.0	parC.l6.c4.ctg.1	3429	137.9	1	SNP	p	R87W	0	.	.	259	261	CGT	747	749	CGT	173;174;172	C;G;T	142;146;147	parC.WHO_Y_00247c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	1578	parC	2304	2304	100.0	parC.l6.c4.ctg.1	3429	137.9	1	SNP	p	S87R	1	.	.	259	261	CGT	747	749	CGT	173;174;172	C;G;T	142;146;147	parC.WHO_Y_00247c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	1578	parC	2304	2304	100.0	parC.l6.c4.ctg.1	3429	137.9	1	SNP	p	R87I	0	.	.	259	261	CGT	747	749	CGT	173;174;172	C;G;T	142;146;147	parC.WHO_Y_00247c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	1578	parC	2304	2304	100.0	parC.l6.c4.ctg.1	3429	137.9	1	SNP	p	S88P	0	.	.	262	264	TCC	750	752	TCC	173;175;174	T;C;C	139;142;146	parC.WHO_Y_00247c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	1184	parE	1986	1986	100.0	parE.l15.c4.ctg.1	3190	111.1	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1801	1803	GGC	152;153;154	G,A;G;C	127,1;130;127	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.34.001	penA.34.001	1	1	27	1002	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2949	101.7	1	SNP	p	A311V	0	.	.	931	933	GCC	1558	1560	GCC	144;145;145	G;C,A;C,A	121;121,1;124,1	penA.34.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	1002	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2949	101.7	1	SNP	p	I312M	1	.	.	934	936	ATG	1561	1563	ATG	144;143;143	A;T;G,A	125;122;119,1	penA.34.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	1002	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2949	101.7	1	SNP	p	V316T	1	.	.	946	948	ACC	1573	1575	ACC	142;143;143	A;C,A;C	122;118,1;120	penA.34.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	1002	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2949	101.7	1	SNP	p	T316P	0	.	.	946	948	ACC	1573	1575	ACC	142;143;143	A;C,A;C	122;118,1;120	penA.34.001:1:1:T316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	1002	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2949	101.7	1	SNP	p	T483S	0	.	.	1447	1449	ACC	2074	2076	ACC	141;141;141	A;C;C,G	117;114;113,1	penA.34.001:1:1:T483S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	1002	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2949	101.7	1	SNP	p	A501P	0	.	.	1501	1503	GCG	2128	2130	GCG	130;131;132	G;C,T;G	109;106,1;112	penA.34.001:1:1:A501P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	1002	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2949	101.7	1	SNP	p	A501V	0	.	.	1501	1503	GCG	2128	2130	GCG	130;131;132	G;C,T;G	109;106,1;112	penA.34.001:1:1:A501V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	1002	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2949	101.7	1	SNP	p	G542S	0	.	.	1624	1626	GGT	2251	2253	GGT	137;136;135	G;G;T,G	115;117;115,1	penA.34.001:1:1:G542S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	1002	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2949	101.7	1	SNP	p	G545S	1	.	.	1633	1635	AGC	2260	2262	AGC	135;137;137	A;G;C	116;119;118	penA.34.001:1:1:G545S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	1002	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2949	101.7	1	SNP	p	P551S	0	.	.	1651	1653	CCG	2278	2280	CCG	130;131;132	C,G;C;G	104,1;109;111	penA.34.001:1:1:P551S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	1506	ponA	2397	2397	100.0	ponA.l15.c4.ctg.1	3547	127.2	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1877	1879	CCG	123;123;122	C;C,A;G,A	99;100,1;99,1	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	808	porA	1146	1146	99.91	porA.l6.c30.ctg.1	2336	102.1	0	.	p	.	0	M83fs	FSHIFT	247	247	A	940	940	C	132	C	113	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	148	porB1a	984	287	91.07	porB1a.l15.c30.ctg.1	1436	30.0	0	.	p	.	0	H217N	NONSYN	649	651	CAT	1172	1174	AAT	20;20;20	A;A;T	17;17;17	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	148	porB1a	984	287	91.07	porB1a.l15.c30.ctg.1	1436	30.0	0	.	p	.	0	D218N	NONSYN	652	654	GAT	1175	1177	AAT	20;19;19	A;A;T	17;16;15	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	148	porB1a	984	287	91.07	porB1a.l15.c30.ctg.1	1436	30.0	0	.	p	.	0	V226A	NONSYN	676	678	GTA	1199	1201	GCA	18;18;18	G;C;A	15;14;14	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	148	porB1a	984	287	91.07	porB1a.l15.c30.ctg.1	1436	30.0	0	.	p	.	0	.	MULTIPLE	700	702	ACT	1222	1224	GTA	16;16;16	G;T;A	14;13;14	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	148	porB1a	984	287	91.07	porB1a.l15.c30.ctg.1	1436	30.0	0	.	p	.	0	N237fs	FSHIFT	709	709	A	1231	1231	A	15	A	13	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	820	porB1b	1038	1038	99.71	porB1b.l6.c17.ctg.1	2054	117.9	0	.	p	.	0	G48E	NONSYN	142	144	GGA	664	666	GAA	185;184;186	G;A;A	149;148;154	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	820	porB1b	1038	1038	99.71	porB1b.l6.c17.ctg.1	2054	117.9	0	.	p	.	0	G210R	NONSYN	628	630	GGA	1150	1152	AGA	167;167;168	A;G,A;A	146;145,1;142	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	820	porB1b	1038	1038	99.71	porB1b.l6.c17.ctg.1	2054	117.9	0	.	p	.	0	S217G	NONSYN	649	651	AGT	1171	1173	GGT	169;167;167	G;G;T,C	146;143;142,1	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	820	porB1b	1038	1038	99.71	porB1b.l6.c17.ctg.1	2054	117.9	1	SNP	p	G120K	1	.	.	358	360	AAG	880	882	AAG	185;185;186	A;A;G,A	152;154;151,1	porB1b.WHO_Y_02277c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	820	porB1b	1038	1038	99.71	porB1b.l6.c17.ctg.1	2054	117.9	1	SNP	p	A121N	1	.	.	361	363	AAC	883	885	AAC	186;185;185	A,G;A;C	151,1;156;157	porB1b.WHO_Y_02277c:1:1:A121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	820	porB1b	1038	1038	99.71	porB1b.l6.c17.ctg.1	2054	117.9	1	SNP	p	N121D	0	.	.	361	363	AAC	883	885	AAC	186;185;185	A,G;A;C	151,1;156;157	porB1b.WHO_Y_02277c:1:1:N121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	2634	rpoB	4179	4179	99.98	rpoB.l15.c4.ctg.1	5274	149.8	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	396	rpsJ	312	312	100.0	rpsJ.l15.c17.ctg.1	1252	94.0	1	SNP	p	V57M	1	.	.	169	171	ATG	648	650	ATG	159;160;160	A;T;G	136;136;134	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
